Sigilon Therapeutics, Inc. (45) | Uncategorized (8)
Recent Contracts
-
Offer Letter, between Sigilon Therapeutics, Inc. and May Orfali, M.D. dated October 27, 2021
(Filed With SEC on March 14, 2022)
-
Offer Letter, between Sigilon Therapeutics, Inc. and Philip Ashton-Rickardt, dated May 25, 2021
(Filed With SEC on March 14, 2022)
-
Offer Letter, between Sigilon Therapeutics, Inc. and Deya Corzo, M.D. dated September 26, 2018
(Filed With SEC on March 14, 2022)
-
Letter Agreement, dated August 4, 2021, between the Company and Deya Corzo, M.D
(Filed With SEC on March 14, 2022)
-
Description of Registered Securities
(Filed With SEC on March 18, 2021)
-
Offer Letter, between Sigilon Therapeutics, Inc. and Rogerio Vivaldi Coelho, M.D., dated April 23, 2018
(Filed With SEC on November 13, 2020)
-
Offer Letter, between Sigilon Therapeutics, Inc. and Glenn Reicin, dated May 8, 2019
(Filed With SEC on November 13, 2020)
-
Offer Letter, between Sigilon, Inc. and Devyn Smith, dated March 25, 2017
(Filed With SEC on November 13, 2020)